Global Niraparib 麻豆原创 Research Report 2024

Publication ID:

PB505251547

Publication Date:

May 7, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global Niraparib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Niraparib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Niraparib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Niraparib include TESARO and Everest Pharmaceuticals Limited etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Niraparib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Niraparib.
Report Scope
The Niraparib market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Niraparib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Niraparib manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
TESARO
Everest Pharmaceuticals Limited
Segment by Type
100mg*30 Capsules
100mg*60 Capsules
100mg*90 Capsules
Segment by Application
Recurrent Epithelial Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Niraparib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Niraparib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Niraparib 麻豆原创 Overview
1.1 Product Overview and Scope of Niraparib
1.2 Niraparib Segment by Type
1.2.1 Global Niraparib 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 100mg*30 Capsules
1.2.3 100mg*60 Capsules
1.2.4 100mg*90 Capsules
1.3 Niraparib Segment by Application
1.3.1 Global Niraparib 麻豆原创 Value by Application: (2024-2030)
1.3.2 Recurrent Epithelial Ovarian Cancer
1.3.3 Fallopian Tube Cancer
1.3.4 Primary Peritoneal Cancer
1.3.5 Others
1.4 Global Niraparib 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Niraparib Revenue 2019-2030
1.4.2 Global Niraparib Sales 2019-2030
1.4.3 Global Niraparib 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Niraparib 麻豆原创 Competition by Manufacturers
2.1 Global Niraparib Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Niraparib Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Niraparib Average Price by Manufacturers (2019-2024)
2.4 Global Niraparib Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Niraparib, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Niraparib, Product Type & Application
2.7 Niraparib 麻豆原创 Competitive Situation and Trends
2.7.1 Niraparib 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Niraparib Players 麻豆原创 Share by Revenue
2.7.3 Global Niraparib 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Niraparib Retrospective 麻豆原创 Scenario by Region
3.1 Global Niraparib 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Niraparib Global Niraparib Sales by Region: 2019-2030
3.2.1 Global Niraparib Sales by Region: 2019-2024
3.2.2 Global Niraparib Sales by Region: 2025-2030
3.3 Global Niraparib Global Niraparib Revenue by Region: 2019-2030
3.3.1 Global Niraparib Revenue by Region: 2019-2024
3.3.2 Global Niraparib Revenue by Region: 2025-2030
3.4 North America Niraparib 麻豆原创 Facts & Figures by Country
3.4.1 North America Niraparib 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Niraparib Sales by Country (2019-2030)
3.4.3 North America Niraparib Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Niraparib 麻豆原创 Facts & Figures by Country
3.5.1 Europe Niraparib 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Niraparib Sales by Country (2019-2030)
3.5.3 Europe Niraparib Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Niraparib 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Niraparib 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Niraparib Sales by Country (2019-2030)
3.6.3 Asia Pacific Niraparib Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Niraparib 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Niraparib 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Niraparib Sales by Country (2019-2030)
3.7.3 Latin America Niraparib Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Niraparib 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Niraparib 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Niraparib Sales by Country (2019-2030)
3.8.3 Middle East and Africa Niraparib Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Niraparib Sales by Type (2019-2030)
4.1.1 Global Niraparib Sales by Type (2019-2024)
4.1.2 Global Niraparib Sales by Type (2025-2030)
4.1.3 Global Niraparib Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Niraparib Revenue by Type (2019-2030)
4.2.1 Global Niraparib Revenue by Type (2019-2024)
4.2.2 Global Niraparib Revenue by Type (2025-2030)
4.2.3 Global Niraparib Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Niraparib Price by Type (2019-2030)
5 Segment by Application
5.1 Global Niraparib Sales by Application (2019-2030)
5.1.1 Global Niraparib Sales by Application (2019-2024)
5.1.2 Global Niraparib Sales by Application (2025-2030)
5.1.3 Global Niraparib Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Niraparib Revenue by Application (2019-2030)
5.2.1 Global Niraparib Revenue by Application (2019-2024)
5.2.2 Global Niraparib Revenue by Application (2025-2030)
5.2.3 Global Niraparib Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Niraparib Price by Application (2019-2030)
6 Key Companies Profiled
6.1 TESARO
6.1.1 TESARO Corporation Information
6.1.2 TESARO Description and Business Overview
6.1.3 TESARO Niraparib Sales, Revenue and Gross Margin (2019-2024)
6.1.4 TESARO Niraparib Product Portfolio
6.1.5 TESARO Recent Developments/Updates
6.2 Everest Pharmaceuticals Limited
6.2.1 Everest Pharmaceuticals Limited Corporation Information
6.2.2 Everest Pharmaceuticals Limited Description and Business Overview
6.2.3 Everest Pharmaceuticals Limited Niraparib Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Everest Pharmaceuticals Limited Niraparib Product Portfolio
6.2.5 Everest Pharmaceuticals Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Niraparib Industry Chain Analysis
7.2 Niraparib Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Niraparib Production Mode & Process
7.4 Niraparib Sales and 麻豆原创ing
7.4.1 Niraparib Sales Channels
7.4.2 Niraparib Distributors
7.5 Niraparib Customers
8 Niraparib 麻豆原创 Dynamics
8.1 Niraparib Industry Trends
8.2 Niraparib 麻豆原创 Drivers
8.3 Niraparib 麻豆原创 Challenges
8.4 Niraparib 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

TESARO
Everest Pharmaceuticals Limited

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.